Biegus, Jan http://orcid.org/0000-0001-9977-7722
Pagnesi, Matteo
Davison, Beth
Ponikowski, Piotr
Mebazaa, Alexander
Cotter, Gadi
Funding for this research was provided by:
Uniwersytet Medyczny im. Piastów Slaskich we Wroclawiu (SUBZ.A460.24.040)
Article History
Accepted: 7 July 2024
First Online: 22 July 2024
Declaration
:
: J.B. has received honoraria from Bayer, Boehringer Ingelheim, and AstraZeneca for lectures. J.B. is also an associate Editor of the Heart Failure Reviews. M.P. has received personal fees from Abbott Laboratories, AstraZeneca, Boehringer Ingelheim and Vifor Pharma. MA has received speaker fees from Abbott Vascular and Medtronic. A.M. has received grants from Roche Diagnostics, Abbott Laboratories, 4TEEN4, and Windtree Therapeutics; honoraria for lectures from Roche Diagnostics, Bayer, and MSD; is a consultant for Corteria Pharmaceuticals, S-form Pharma, FIRE-1, Implicity, 4TEEN4, and Adrenomed; and is coinventor of a patent on combination therapy for patients having acute or persistent dyspnoea. P.P. reports personal fees from Boehringer Ingelheim, AstraZeneca, Servier, Bristol Myers Squibb, Amgen, Novartis, Merck, Pfizer, Berlin Chemie, and grants and personal fees from Vifor Pharma. G.C. is employee of Momentum Research, which has received grants for research from Abbott Laboratories, Amgen, Celyad, Cirius Therapeutics, Corteria Pharmaceuticals, Heart Initiative, Sanofi, Windtree Therapeutics, and XyloCor Therapeutics. G.C. is director of Heart Initiative, a non-profit organization. G.C. is also an associate Editor of the Heart Failure Reviews. B.D. is employee of Momentum Research, which has received grants for research from Abbott Laboratories, Amgen, Celyad, Cirius Therapeutics, Corteria Pharmaceuticals, Heart Initiative, Sanofi, Windtree Therapeutics, and XyloCor Therapeutics. B.D. is director of Heart Initiative, a non-profit organization. B.D. is also an associate Editor of the Heart Failure Reviews.